Related Experiment Video
Updated: Jun 10, 2026
11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
EBNA1 and LMP1 variants in multiple sclerosis cases and controls
K C Simon1, X Yang, K L Munger
1Department of Nutrition, Harvard School of Public Health, Boston, MA, USA. ksimon@hsph.harvard.edu
Acta Neurologica Scandinavica
|July 20, 2010
Summary
Epstein-Barr virus (EBV) strain variation in EBNA1 and LMP1 genes does not appear to significantly influence multiple sclerosis (MS) risk. This study found no strong association between specific EBV variants and MS development.
Area of Science:
- Neurology
- Virology
- Immunology
Background:
- Epstein-Barr virus (EBV) infection is a known risk factor for multiple sclerosis (MS).
- Observed variations in MS prevalence and potential epidemics may be linked to different EBV strains.
- Investigating EBV strain differences could clarify its role in MS pathogenesis.
Purpose of the Study:
- To investigate whether variations in specific Epstein-Barr virus (EBV) genes (EBNA1 and LMP1) are associated with an increased risk of developing multiple sclerosis (MS).
- To compare the prevalence of different EBV strains and their mutations in individuals with MS versus healthy controls.
Main Methods:
- DNA was extracted from lymphocytes of 66 MS cases and 66 matched controls.
- Nested PCR was used to amplify EBNA1 (N- and C-terminus) and LMP1 gene regions.
- Sequencing compared prototype vs. variant EBNA1 strains and analyzed LMP1 mutations in relation to MS status and antibody titers.
Main Results:
- No significant differences were found in the proportion of EBNA1 N-terminal or C-terminal variants between MS cases and controls.
- No individual LMP1 variants were significantly associated with MS risk.
- Neither EBNA1 nor LMP1 genetic variations correlated with anti-EBNA1 IgG antibody levels.
Conclusions:
- The study's findings do not support a significant role for variations in the EBNA1 N-terminus, EBNA1 C-terminus, or LMP1 genes in contributing to multiple sclerosis risk.
- Further research may be needed to explore other EBV factors or host-pathogen interactions in MS development.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...